In TNBC, Pathologic Complete Response May Vary by Race/Ethnicity

(MedPage Today) -- Among patients with triple-negative breast cancer (TNBC) who received neoadjuvant chemotherapy, the odds of achieving pathologic complete response (pCR) and improved overall survival (OS) may vary by race/ethnicity, according...
Source: MedPage Today Public Health - Category: American Health Source Type: news